Indeed, PPIL2 transcription was substantially upregulated in patients with MPN, regardless of the disease subtype (Figure 3O) and mutation status (Figure 3P), which is consistent with the fact that the JAK/STAT pathway is ubiquitously activated in MPNs (1). This evidence concerns the gene PPIL2 and myeloproliferative neoplasm.